Implementation and effectiveness of a delirium care protocol in Thai critically ill children

Chanapai Chaiyakulsil1, Thananya Thadahirunchot2

  • 1Division of Pediatric Critical Care, Department of Pediatrics, Thammasat University Hospital, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.

Acute and Critical Care
|December 5, 2023
PubMed

Insights

A new protocol reduced delirium duration in critically ill children with cardiovascular issues. Further research is needed to prevent long-term morbidity after pediatric intensive care unit discharge.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pediatric Neurology
  • Clinical Protocol Implementation

Background:

  • Delirium in critically ill children is linked to long-term negative health outcomes.
  • Identifying risk factors and effective interventions is crucial for improving pediatric patient care.
  • Current management strategies require evaluation for optimal efficacy.

Purpose of the Study:

  • To assess a new protocol's impact on pediatric delirium.
  • To evaluate changes in delirium prevalence and duration.
  • To identify risk factors associated with delirium in critically ill children.

Main Methods:

  • Chart review of critically ill children (1 month-15 years).
  • Cornell Assessment of Pediatric Delirium score used for diagnosis (≥9).
  • Comparison of pre- and post-protocol implementation phases; univariate and multivariate analyses for risk factors.

Main Results:

  • 120 children analyzed; 41.7% screened positive for delirium.
  • Younger age (<2 years), developmental delay, mechanical ventilation, and prolonged PICU stay (>7 days) were risk factors.
  • Protocol did not significantly alter overall delirium prevalence but reduced duration in cardiovascular cases.

Conclusions:

  • The new protocol effectively reduced delirium duration in children with cardiovascular conditions and post-cardiothoracic surgery.
  • Further research is necessary to develop strategies for delirium reduction and prevention of long-term morbidity post-PICU discharge.
Abstract

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...